Biotech and medical business blog

Visit BioHealth Investor

Barrier Therapeutics Huge Premium Buyout (BTRX)

Posted on June 23, 2008

Barrier Therapeutics, Inc. (NASDAQ:BTRX) is seeing shares surge after it has signed a merger agreement with Stiefel Laboratories, Inc., the world s largest independent pharmaceutical company specializing in dermatology.Stiefel Laboratories will purchase all of the outstanding stock of Barrier Therapeutics in a cash buyout valued at $4.15 per share. This price is a 73% premium [...]...

Original article link